Clinical Trial Update: ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating ZD6474 (Zactima) in combination with metronomic chemotherapy for metastatic breast cancer, sponsored by Dana-Farber Can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zactima (vandetanib) (vandetanib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED